1. All
  2. Press Releases
  3. Events
  4. Publications

Primo Biotech’s Innovative Radiopharmaceutical Enrolls First Patient, Marking a New Milestone in Precision Medicine for Colorectal Cancer

Press Releases

Advancing Early Detection: PSMA PET and Biomarkers Redefine Prostate Cancer Diagnosis

Press Releases

Primo Biotechnology and Anbogen Therapeutics Forge Strategic Collaboration to Co-Develop Precision Radioligand for Solid Tumors Diagnosis and Therapy

Press Releases

Primo Biotechnology and Terthera B.V. Announce Strategic Partnership to Advance Terbium-161 Radioligand Therapies in Taiwan

Press Releases
普瑞默生技完成A輪募資 目標2026啟動IPO布局全球放射藥物市場

Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy

Press Releases

Primo’s Taoyuan Facility Achieves PIC/S GMP Certification, Paving the Way for Global Expansion in Nuclear Medicine.

Press Releases

Primo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market

Press Releases

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Press Releases

Primo Biotechnology Partners with Antelope Surgical Solutions for World’s First FDA-Approved Phase I/II Trial of AS1986NS

Press Releases

Primo wins 2023 TAIPEI Prominent Enterprise Award

Press Releases

Primo Biotechnology Raises Over 6.5 Million USD in Funding, Pioneering an International-level Radiopharmaceutical Manufacturing Facility

Press Releases

Dr. Chi-Wei Chang joins Primo as CTO of Radiopharmaceutical Chemistry.

Press Releases